People: Arrowhead Research Corp (ARWR.O)

ARWR.O on Nasdaq

12.35USD
11 Jul 2014
Price Change (% chg)

$0.13 (+1.06%)
Prev Close
$12.22
Open
$12.21
Day's High
$12.43
Day's Low
$12.00
Volume
766,508
Avg. Vol
2,051,261
52-wk High
$27.63
52-wk Low
$2.25

Search Stocks

McKenney, Charles 

Brief Biography

Mr. Charles P. McKenney is Independent Director of Arrowhead Research Corp. He has been a director of the Company since April 2004. Mr. McKenney has maintained a government affairs law practice in Pasadena, California since 1989, representing businesses and organizations in their relations with state and local government regarding their obligations under state and local land use and trade practices laws. From 1973 through 1989, he served as Attorney for Corporate Government Affairs for Sears, Roebuck and Co., helping organize and carry out Sears’s western state and local government relations programs. Mr. McKenney has served two terms on the Pasadena, California, City Council as well as on several city boards and committees, including three city Charter Reform Task Forces. Mr. McKenney is a director of Arrowhead’s majority-owned subsidiaries Calando Pharmaceuticals, Inc., Ablaris Therapeutics, Inc., and Tego Biosciences Corporation. We believe Mr. McKenney’s qualifications to serve on the Board include his long tenure as a member of the Board resulting in a deep understanding of the Company’s operations, strategy and finances. Mr. McKenney also has extensive experience providing strategic legal and advisory services to developmental stage organizations.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks